Clinical trialNCT01031680CompletedPhase 3Interventional

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension

SponsorAstraZenecaEnrollment922Cardiovascular DiseaseHypertensionInadequate Glycaemic ControlType 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dr. William Cefalu
Pennington Biomedical Research Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

140 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
La Plata, Buenos Aires, Argentina
Research Site
Buenos Aires, Buenos Aires F.D., Argentina
Research Site
Caba, Buenos Aires F.D., Argentina
Research Site
Córdoba, Córdoba Province, Argentina
Research Site
Mendoza, Mendoza Province, Argentina
Research Site
Santa Fe, Santa Fe Province, Argentina
Research Site
Buenos Aires, Argentina
Research Site
Ciudad de Buenos Aires, Argentina

Canada

Research Site
Calgary, Alberta, Canada
Research Site
New Westminster, British Columbia, Canada
Research Site
Winnipeg, Manitoba, Canada
Research Site
Carbonear, Newfoundland and Labrador, Canada
Research Site
Mount Pearl, Newfoundland and Labrador, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Courtice, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Mississauga, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Smiths Falls, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Lachine, Quebec, Canada
Research Site
Laval, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Saint-Marc-des-Carrieres, Quebec, Canada
Research Site
Sherbrooke, Quebec, Canada

Germany

Research Site
Potsdam, BR, Germany
Research Site
Bad Nauheim, Germany
Research Site
Berlin, Germany
Research Site
Erdmannhausen, Germany
Research Site
Frankfurt, Germany
Research Site
Hamburg, Germany
Research Site
Heilbronn, Germany
Research Site
Hildesheim, Germany
Research Site
Mainz, Germany
Research Site
Münster, Germany
Research Site
Potsdam, Germany
Research Site
Speyer, Germany
Research Site
Wahlstedt, Germany

Romania

Research Site
Brasov, Brașov County, Romania
Research Site
Suceava, Suceava, Romania

100 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 2010
Primary completion: 31 May 2011
Completion: 31 Dec 2012
Last update posted: 29 Oct 2013
Registered enrollment: 922
Registry id: NCT01031680

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.